Success Metrics

Active Trials

2(67%)

Phase Distribution

Ph phase_4

33%

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Other(1)

Detailed Status

Recruiting1

Active, not recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 4

Trials by Phase

Phase 41 (33.3%)

N/A2 (66.7%)

Trials by Status

recruiting133%

active_not_recruiting133%

unknown133%

Recent Activity

2 active trials

Showing 3 of 3

active_not_recruitingphase_4

Venous Closure System After AF Ablation

NCT07814144

recruitingnot_applicable

Suture-Mediated Closure System Following Percutaneous Common Femoral Vein Procedures

NCT07554976

unknownnot_applicable

Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease

NCT05334095

Clinical Trials (3)

Showing 3 of 3 trials

NCT07814144Phase 4

Venous Closure System After AF Ablation

Active Not Recruiting

NCT07554976Not Applicable

Suture-Mediated Closure System Following Percutaneous Common Femoral Vein Procedures

Recruiting

NCT05334095Not Applicable

Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease

Unknown

All 3 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 3